⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL15993555 | 0.84 | ALDH1A1 (0.33) | — | |
| SCHEMBL11153107 | 0.83 | — | — | |
| Domiodol SCHEMBL11633809 | 0.83 | — | — | |
| SCHEMBL13455763 | 0.83 | — | — | |
| SCHEMBL4864294 | 0.83 | — | — | |
| SCHEMBL12535579 | 0.83 | — | — | |
| SCHEMBL9172771 | 0.83 | — | — | |
| Domiodol SCHEMBL19352 | 0.83 | — | — | |
| SCHEMBL9181813 | 0.83 | — | — | |
| SCHEMBL10817323 | 0.80 | ALDH1A1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 530 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240082417-A1 | PROTEIN-POLYMER DRUG CONJUGATES | ASANA BIOSCIENCES, LLC | 2024-03-14 | — | — | US | claimed |
| EP-4302782-A2 | NAPI2B-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF | Mersana Therapeutics, Inc. (US) | 2024-01-10 | — | — | EP | claimed |
| EP-3641826-B1 | METHODS OF PRODUCING DRUG-CARRYING POLYMER SCAFFOLDS AND PROTEIN-POLYMER-DRUG CONJUGATES | MERSANA THERAPEUTICS INC (US) | 2023-12-06 | — | — | EP | claimed |
| US-20230338569-A1 | NaPi2b-TARGETED POLYMER ANTIBODY-DRUG CONJUGATE FOR THE TREATMENT OF OVARIAN CANCER | MERSANA THERAPEUTICS, INC. | 2023-10-26 | — | — | US | claimed |
| US-20230312747-A1 | Compositions and Methods for Treating Cancer | SEAGEN INC. (US) | 2023-10-05 | — | — | US | claimed |
| EP-3429693-B1 | NAPI2B-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF | MERSANA THERAPEUTICS INC (US) | 2023-08-23 | — | — | EP | claimed |
| EP-3157959-B1 | MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF | MERSANA THERAPEUTICS INC (US) | 2023-08-02 | — | — | EP | claimed |
| US-20230183326-A1 | PROTEIN-POLYMER-DRUG CONJUGATES | ASANA BIOSCIENCES, LLC | 2023-06-15 | — | — | US | claimed |
| WO-2023039512-A1 | NAPI2B-TARGETED POLYMER ANTIBODY-DRUG CONJUGATE FOR THE TREATMENT OF OVARIAN CANCER | MERSANA THERAPEUTICS, INC. (US) | 2023-03-16 | — | — | WO | claimed |
| EP-3475284-B1 | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF | MERSANA THERAPEUTICS INC (US) | 2022-11-02 | — | — | EP | claimed |
| WO-2011116026-A2 | INHIBITORS OF BETA INTEGRIN-G PROTEIN ALPHA SUBUNIT BINDING INTERACTIONS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2011-09-22 | — | — | WO | claimed |
| EP-2349341-A2 | PEGYLATION OF RECOMBINANT BLOOD COAGULATION FACTORS IN THE PRESENCE OF BOUND ANTIBODIES | Baxter Healthcare SA (CH) | 2011-08-03 | — | — | EP | claimed |
| EP-1667726-B1 | POLYACETAL DRUG CONJUGATES AS RELEASE SYSTEM | GEN HOSPITAL CORP (US) | 2011-05-04 | — | — | EP | claimed |
| US-20110059010-A1 | DUAL PHASE DRUG RELEASE SYSTEM | THE GENERAL HOSPITAL CORPORATION (US) | 2011-03-10 | — | — | US | claimed |
| US-20110028693-A1 | BLOOD COAGULATION PROTEIN CONJUGATES | BAXTER INTERNATIONAL INC. (US) | 2011-02-03 | — | — | US | claimed |
| WO-2010045321-A2 | PEGYLATION OF RECOMBINANT BLOOD COAGULATION FACTORS IN THE PRESENCE OF BOUND ANTIBODIES | BAXTER INTERNATIONAL INC. (US) | 2010-04-22 | — | — | WO | claimed |
| US-20100093934-A1 | PEGYLATION OF RECOMBINANT BLOOD COAGULATION FACTORS IN THE PRESENCE OF BOUND ANTIBODIES | BAXTER INTERNATIONAL INC. (US) | 2010-04-15 | — | — | US | claimed |
| US-6822086-B1 | HAVING REVERSIBLE ASSOCIATIONS; FOR DRUG SCREENING/TARGETING | THE GENERAL HOSPITAL CORPORATION | 2004-11-23 | — | — | US | claimed |
| EP-1206285-A2 | DRUG-CARRIER COMPLEXES AND METHODS OF USE THEREOF | THE GENERAL HOSPITAL CORPORATION (US) | 2002-05-22 | — | — | EP | claimed |
| WO-2001010468-A2 | DRUG-CARRIER COMPLEXES AND METHODS OF USE THEREOF | THE GENERAL HOSPITAL CORPORATION (US) | 2001-02-15 | — | — | WO | claimed |